Report - CONGRESS CORE FACTS hematooncology · Potenzial haben, die Therapie des multiplen Myeloms zu verändern. Hier sei in erster Linie die PANORAMA-Studie, eine Phase-3-Studie zu Panobinostat,

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form